Search research articles
Contact Us
Filters
Showing results (121-130 of 190) with videos related to
Page
of 19
Sort By:
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care
|
March 6, 2018
Quality of care and variability in lung cancer management across Belgian hospitals: a population-based study using routinely available data
France Vrijens, Cindy De Gendt, Leen Verleye, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 16, 2010
Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma
Kevin Hollevoet, Kristiaan Nackaerts, Joël Thimpont, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 2, 2011
A double-blind, randomised, placebo-controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum-based chemotherapy (EORTC 08021/ILCP 01/03)
Rabab M Gaafar, Veerle F Surmont, Giorgio V Scagliotti, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 9, 2026
Multi-omic screening for pleural mesothelioma in Asbestos-Exposed Populations: A literature review and Recommendations
Kathleen Zwijsen, Ellen Heirwegh, Eline Schillebeeckx, et al.
The European Respiratory Journal
|
December 25, 2014
Estimation of post-operative forced expiratory volume by functional respiratory imaging
Annelies Janssens, Wim Vos, Cedric Van Holsbeke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2005
Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada
Jan P van Meerbeeck, Rabab Gaafar, Christian Manegold, et al.
Oncoimmunology
|
February 16, 2017
Prognostic and predictive aspects of the tumor immune microenvironment and immune checkpoints in malignant pleural mesothelioma
Elly Marcq, Vasiliki Siozopoulou, Jorrit De Waele, et al.
Critical Reviews in Oncology/Hematology
|
April 30, 2015
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis
Giuseppe Bronte, Christian Rolfo, Francesco Passiglia, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 27, 2014
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: an individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent study validation
Baktiar Hasan, Laurent Greillier, Athanasios Pallis, et al.
Acta Chirurgica Belgica
|
April 13, 2017
Malignant pleural mesothelioma: single-institution experience of 101 patients over a 15-year period
Andreas Domen, Christophe De Laet, Wies Vanderbruggen, et al.
Page
of 19
Search research articles
Search
Showing results (121-130 of 190) with videos related to
Sort By:
Page
of 19
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care
|
March 6, 2018
Quality of care and variability in lung cancer management across Belgian hospitals: a population-based study using routinely available data
France Vrijens, Cindy De Gendt, Leen Verleye, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 16, 2010
Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma
Kevin Hollevoet, Kristiaan Nackaerts, Joël Thimpont, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 2, 2011
A double-blind, randomised, placebo-controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum-based chemotherapy (EORTC 08021/ILCP 01/03)
Rabab M Gaafar, Veerle F Surmont, Giorgio V Scagliotti, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 9, 2026
Multi-omic screening for pleural mesothelioma in Asbestos-Exposed Populations: A literature review and Recommendations
Kathleen Zwijsen, Ellen Heirwegh, Eline Schillebeeckx, et al.
The European Respiratory Journal
|
December 25, 2014
Estimation of post-operative forced expiratory volume by functional respiratory imaging
Annelies Janssens, Wim Vos, Cedric Van Holsbeke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2005
Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada
Jan P van Meerbeeck, Rabab Gaafar, Christian Manegold, et al.
Oncoimmunology
|
February 16, 2017
Prognostic and predictive aspects of the tumor immune microenvironment and immune checkpoints in malignant pleural mesothelioma
Elly Marcq, Vasiliki Siozopoulou, Jorrit De Waele, et al.
Critical Reviews in Oncology/Hematology
|
April 30, 2015
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis
Giuseppe Bronte, Christian Rolfo, Francesco Passiglia, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 27, 2014
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: an individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent study validation
Baktiar Hasan, Laurent Greillier, Athanasios Pallis, et al.
Acta Chirurgica Belgica
|
April 13, 2017
Malignant pleural mesothelioma: single-institution experience of 101 patients over a 15-year period
Andreas Domen, Christophe De Laet, Wies Vanderbruggen, et al.
Page
of 19